Writing a quality proposal requires time, energy and thought, three commodities in short supply when you’re teaching a full class load. If you’re an A&T faculty researcher in health science who would benefit from release from one class to prepare a competitive proposal, we have an opportunity for you. And it’s an opportunity with a short turn-around time.
Applications are being taken through Monday November 17 for faculty release time from one class during the Spring 2015 semester to develop a proposal in the health science area in response to a solicitation from an external sponsor. The number of faculty members receiving funding will be limited only by the quality of proposals submitted by the November 17 deadline.
Apply only if you will work on a proposal due in late summer 2015 or early fall 2015. Spring 2015 deadlines are too close for faculty to benefit from this opportunity.
A question-and-answer session will be held on Wednesday November 5, 5:30 p.m., in the Fort IRC, Room 410.
Full details are here.
This is an especially good opportunity to collaborate with researchers at UNC Chapel Hill and RTI International, A&T’s partners in the North Carolina Translational and Clinical Sciences Institute (NC TraCS). A&T faculty members are encouraged, but not required, to consider how their research interests may coincide with the priorities of NC TraCS.
Dr. Perpetua Muganda, professor in A&T’s Department of Biology, will be featured in a segment on UNC-TV’s North Carolina Now this evening (October 15). Muganda and a team of researchers from A&T and UNC-CH are investigating the role of viral factors in the aggressive nature of triple-negative breast cancer. Their work will be included in a special October report on breast cancer.
The program will air on UNC-TV at 7:30 p.m. EDT and on UNC-MX at 11 p.m.
Dr. Muganda’s study is funded by a grant from the NC TraCS Institute at UNC-CH and money from both universities. A&T and RTI International are partners with UNC-CH on its current Clinical and Translational Sciences Award from the National Institutes of Health.
The team bringing safer peanuts to the world (from left): Wayne Szafranski, A&T director of economic outreach; Barry Burks, vice chancellor for research; Louis Judge, director of technology transfer; Jianmei Yu, research scientist; Johnny Rodrigues, Alrgn Bio founder; and Ann Russell, Alrgn director of U.S. operations.
The world’s first commercially available hypoallergenic peanuts have officially emerged from the laboratory.
Alrgn Bio, exclusive licensee of the hypoallergenic process patented by North Carolina Agricultural and Technical State University, has opened an office in the Gateway University Research Park. Batches of peanuts are available to the food industry for evaluation, Alrgn announced today.
“We have received tremendous interest since we announced in June that the technology is available,” said Johnny Rodrigues, Alrgn founder.
“We will work with food processors and manufacturers to establish this process as the industry standard for peanuts and peanut-derived ingredients. We’ll work together to deliver safer peanut products to consumers as quickly as possible.”
Alrgn made the announcement Thursday at its demonstration facility at the Gateway University Research Park in Greensboro, North Carolina. Alrgn is a spin-off of N.C. A&T and Xemerge, the North Carolina- and Toronto-based technology development company that originally licensed the A&T peanut technology.
Posted in Agriculture, Biomedical Research, Biotechnology, Economic Development, Gateway University Research Park, Translational and Clinical Science
Tagged Alrgn Bio, Ann Russell, Barry Burks, Dr. Jianmei Yu, hypoallergenic peanuts, Johnny Rodrigues, Louis Judge, Wayne Szafranski, Xemerge
To all who were gone over the summer, welcome back. Here’s a rundown of the top research-related news at A&T since May:
Faculty members, department chairs, and deans: We want to write about your research, scholarly and creative activity! Let us know about it; click here for email.
Posted in Agriculture, Biomedical Research, Biotechnology, Engineering, Faculty, Funders, Grants, JSNN, Nano, NIH, NSF, Technology Transfer, Translational and Clinical Science
Tagged clinical and translational science, COPD, Eco-Core, Engineering Projects in Community Service, EPICS, hypoallergenic peanuts, NC TraCS, NIH, NSF, triple negative breast cancer
A leader of the NC TraCS Institute will visit campus on Tuesday and throughout the semester to answer faculty members’ questions about biomedical, health sciences and translational research funded by the institute.
Dr. David Carroll, Director, Research Funding Development, will be be in the Fort IRC, Room 408, on Tuesday, August 12th, 9:30 a.m. to 4:15 p.m.
If you or a colleague at A&T are working on an NC TraCS or NIH proposal or have questions about the NC TraCS/NIH proposal process, please click here to sign up for an appointment to meet with him.
Dr. Carroll will be on campus twice monthly this semester. Contact Dr. Laura Collins, 285-3188 for specific dates.
The next monthly NC TraCS $2K proposal deadlines are August 19 and September 16.
The next NC TraCS $50K proposal deadline is November 4. These proposals require a biostats consultation in advance of submission.
A hold-the-date note from our partners at the NC TraCS Institute at UNC-Chapel Hill:
On behalf of Dr. Marshall Runge, principal investigator of the CTSA, we are sending this note so that you are aware that plans are in the works for an NC TraCS Institute Open House on Wednesday October 1st.
The goal is to educate and inform the research community about our services, our accomplishments, and our vision for the future of TraCS. More details will follow. If you have any questions please contact Ben Gellman-Chomsky.
In particular, researchers in these and related fields are invited:
- Allied Health
- Biochemistry & Biophysics
- Exercise & Sports Science
- Information & Library Science
- Journalism & Mass Communication
- Microbiology & Immunology
- Public Health
- Social Work
Click here for information on N.C. A&T’s role with NC TraCS in the Clinical and Translations Science Awards program.